The serendipitous discovery revolutionizing regenerative aesthetics
During his groundbreaking cancer research at AIVITA Biomedical, world-renowned stem cell scientist Dr. Hans Keirstead made an extraordinary discovery: the complete skin secretome. This serendipitous finding, born from research aimed at solving humanity’s greatest medical challenges, would become the cornerstone of LevEllis’ mission and revolutionary new product, PROVOQUE.
Provocative innovation
We are committed to advancing the science of aesthetic medicine through rigorous research and cutting-edge technologies.
Clinical precision
Placing patient well-being and satisfaction at the core of every decision—from product development to post-treatment.
Bold scientific authority
Providing trusted expertise for healthcare professionals and patients, ensuring ethical integrity, responsible use and informed treatment.
Provocative innovation
We are committed to advancing the science of aesthetic medicine through rigorous research and cutting-edge technologies.
Clinical precision
Placing patient well-being and satisfaction at the core of every decision—from product development to post-treatment.
Bold scientific authority
Providing trusted expertise for healthcare professionals and patients, ensuring ethical integrity, responsible use and informed treatment.
Unlocking new possibilities in regenerative aesthetics
Inspired by Dr. Keirstead’s discovery of the skin-specific, fetuin-A-powered secretome, our mission is to remain dedicated to setting a new standard in topical aesthetics by continuously pursuing breakthrough discoveries that challenge conventional approaches and awaken skin’s full regenerative power.
Leadership
Laura Ellis, MD
Co-founder, CEO
- 20+ years as general surgeon, molecular biologist, & entrepreneur in cosmetic surgery.
- Pioneer in medical spa industry as owner/operator of multiple large chain practices generating $75M+ over 10 yrs.
- Commercialized multiple novel technologies including medical laser protocols, TBI treatments & biometric data acquisition (IoT).
- Piloted Root of Skin 3 years in practice; selected to commercialize PROVOQUE™.
- MD, UNC Chapel Hill; BS Biochemistry & Molecular Biology, NC State University.
Leadership
Hans Keirstead, PhD
Inventor
- 30+ years, internationally recognized stem cell expert & entrepreneur in regenerative medicine; CEO Aivita Biomedical.
- Leads development of therapies for cancer, immune disorders, motor neuron disease, spinal cord injury, retinal disease, and a multi-pathogen vaccine kit.
- Leads Human Immunome Project, a global non-profit sequencing the immune system.
- Post Doctoral, Neurobiology, University of Cambridge; PhD Neurobiology & BS Cell Biology, The University of British Columbia.
Leadership
Shannon Crothers
Chief Operating Officer
- 25+ years leadership focused on life sciences & aesthetics in physician-dispensed, cash-pay companies, including Galderma/ALASTIN, Carl Zeiss, Metagenics, ResMed, Obalon, and Sequenom.
- Most recently Vice President Commercial Operations at ALASTIN Skincare (acquired by Galderma), scaling revenue by 4x in <4 years.
- Commercialized Obalon Therapeutics (cash pay, Class III medical device for weight loss) achieving $8M first year revenues.
- MBA, Santa Clara University; BS, U.S. Coast Guard Academy.
Let’s redefine the future of aesthetics
Ready to unlock the power of regenerative skincare? Connect with us to learn more about the breakthrough science behind PROVOQUE.
A breakthrough in anti-aging skincare.
Explore the science behind skin renewal and discover how PROVOQUE harnesses the complete skin secretome—powered by fetuin-A—to unlock your skin’s regenerative potential.